Lista de obras -

123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma

artículo científico publicado en 2015

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

artículo científico publicado en 2015

Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials

artículo científico publicado en 2006

Antibiotic and other lock treatments for tunnelled central venous catheter related infections in children with cancer

artículo científico publicado en 2011

Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer

artículo científico publicado en 2013

Cardioprotective interventions for cancer patients receiving anthracyclines

artículo científico publicado en 2011

Cardioprotective interventions for cancer patients receiving anthracyclines

scientific article (published 2008-04-23)

Chemotherapy for children with medulloblastoma

artículo científico publicado en 2007

Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines.

artículo científico publicado en 2006

Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study

artículo científico publicado en 2006

Clinical heart failure in children, adolescents and young adults treated with anthracyclines and/or irradiation involving the heart region

artículo científico publicado en 2013

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

artículo científico publicado en 2015

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

artículo científico publicado en 2012

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

artículo científico publicado en 2010

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

artículo científico publicado en 2006

Dexrazoxane in Children With Cancer: From Evidence to Practice

artículo científico publicado en 2015

Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study

artículo científico publicado en 2019

Different anthracycline derivates for reducing cardiotoxicity in cancer patients

artículo científico publicado en 2010

Different anthracycline derivates for reducing cardiotoxicity in cancer patients

artículo científico publicado en 2010

Different anthracycline derivates for reducing cardiotoxicity in cancer patients

artículo científico publicado en 2006

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy

artículo científico publicado en 2009

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy

artículo científico publicado en 2006

Different infusion durations for preventing platinum-induced hearing loss in children with cancer

artículo científico publicado en 2014

Different infusion durations for preventing platinum-induced hearing loss in children with cancer

artículo científico publicado en 2013

Different infusion durations for preventing platinum-induced hearing loss in children with cancer

artículo científico publicado en 2016

Different infusion durations for preventing platinum-induced hearing loss in children with cancer

artículo científico publicado en 2018

Different infusion durations for preventing platinum-induced hearing loss in children with cancer

artículo científico publicado en 2020

Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung and lymph node metastases in rhabdomyosarcoma

Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for detecting metastases of Ewing sarcoma

artículo científico publicado en 2016

Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study

artículo científico publicado en 2013

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

artículo científico publicado en 2011

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

scientific article published on 15 April 2019

Hepatic late adverse effects after treatment for childhood cancer

artículo científico publicado en 2010

High dose chemotherapy and autologous stem cell rescue for children with high risk neuroblastoma

artículo científico publicado en 2006

High risk of symptomatic cardiac events in childhood cancer survivors

artículo científico publicado en 2012

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma

artículo científico publicado en 2015

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma

artículo científico publicado en 2013

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma

artículo científico publicado en 2010

High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first recurrence of Ewing sarcoma

artículo científico publicado en 2014

High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with metastatic Ewing sarcoma

artículo científico publicado en 2014

Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study

scientific article published on 21 August 2020

Iodine-131-meta-iodobenzylguanidine therapy for patients with high-risk neuroblastoma

artículo científico publicado en 2013

Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia

artículo científico publicado en 2012

MIBG scintigraphy and PET imaging for diagnosing neuroblastoma

artículo científico publicado en 2011

Management of asymptomatic anthracycline-induced cardiac damage after treatment for childhood cancer: a postal survey among Dutch adult and pediatric cardiologists

scientific article published on 01 June 2005

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer

artículo científico publicado en 2014

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer

artículo científico publicado en 2012

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer

artículo científico publicado en 2011

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer

scientific article published on 07 May 2019

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.

artículo científico publicado en 2016

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer

artículo científico publicado en 2011

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer

artículo científico publicado en 2009

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer

artículo científico publicado en 2016

Methotrexate for high-grade osteosarcoma in children and young adults

artículo científico publicado en 2011

Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children

artículo científico publicado en 2015

Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children

artículo científico publicado en 2012

Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children

artículo científico publicado en 2010

Platinum-induced hearing loss after treatment for childhood cancer

artículo científico publicado en 2012

Platinum-induced hearing loss after treatment for childhood cancer

artículo científico publicado en 2016

Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review

scientific article published on 28 July 2009

Prevention of anthracycline-induced cardiotoxicity in children: the evidence

artículo científico publicado en 2007

Quality of systematic reviews in pediatric oncology--a systematic review

artículo científico publicado en 2009

Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group

artículo científico publicado en 2015

Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium

artículo científico publicado en 2019

Response to "cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery".

artículo científico publicado en 2009

Risk and Temporal Changes of Heart Failure Among 5-Year Childhood Cancer Survivors: a DCOG-LATER Study

artículo científico publicado en 2019

Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort Analysis

artículo científico publicado en 2016

Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review

artículo científico publicado en 2005

Should anthracyclines and dexrazoxane be used for children with cancer?

artículo científico publicado en 2011

Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors

artículo científico publicado en 2012

Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer

artículo científico publicado en 2014

Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer

artículo científico publicado en 2011

Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer

artículo científico publicado en 2009

Validation of search filters for identifying pediatric studies in PubMed

artículo científico publicado en 2012

Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study

artículo científico publicado en 2014

Lista de obras de

123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials

Antibiotic and other lock treatments for tunnelled central venous catheter related infections in children with cancer

Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer

Cardioprotective interventions for cancer patients receiving anthracyclines

Cardioprotective interventions for cancer patients receiving anthracyclines

Chemotherapy for children with medulloblastoma

Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines.

Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study

Clinical heart failure in children, adolescents and young adults treated with anthracyclines and/or irradiation involving the heart region

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients

Dexrazoxane in Children With Cancer: From Evidence to Practice

Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study

Different anthracycline derivates for reducing cardiotoxicity in cancer patients

Different anthracycline derivates for reducing cardiotoxicity in cancer patients

Different anthracycline derivates for reducing cardiotoxicity in cancer patients

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy

Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy

Different infusion durations for preventing platinum-induced hearing loss in children with cancer

Different infusion durations for preventing platinum-induced hearing loss in children with cancer

Different infusion durations for preventing platinum-induced hearing loss in children with cancer

Different infusion durations for preventing platinum-induced hearing loss in children with cancer

Different infusion durations for preventing platinum-induced hearing loss in children with cancer

Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung and lymph node metastases in rhabdomyosarcoma

Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG-PET/CT) for detecting metastases of Ewing sarcoma

Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

Hepatic late adverse effects after antineoplastic treatment for childhood cancer

Hepatic late adverse effects after treatment for childhood cancer

High dose chemotherapy and autologous stem cell rescue for children with high risk neuroblastoma

High risk of symptomatic cardiac events in childhood cancer survivors

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma

High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first recurrence of Ewing sarcoma

High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with metastatic Ewing sarcoma

Increased risk of cardiac ischaemia in a pan-European cohort of 36 205 childhood cancer survivors: a PanCareSurFup study

Iodine-131-meta-iodobenzylguanidine therapy for patients with high-risk neuroblastoma

Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia

MIBG scintigraphy and PET imaging for diagnosing neuroblastoma

Management of asymptomatic anthracycline-induced cardiac damage after treatment for childhood cancer: a postal survey among Dutch adult and pediatric cardiologists

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer

Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer

Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer

Methotrexate for high-grade osteosarcoma in children and young adults

Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children

Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children

Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children

Platinum-induced hearing loss after treatment for childhood cancer

Platinum-induced hearing loss after treatment for childhood cancer

Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review

Prevention of anthracycline-induced cardiotoxicity in children: the evidence

Quality of systematic reviews in pediatric oncology--a systematic review

Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium

Response to "cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery".

Risk and Temporal Changes of Heart Failure Among 5-Year Childhood Cancer Survivors: a DCOG-LATER Study

Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort Analysis

Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review

Should anthracyclines and dexrazoxane be used for children with cancer?

Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors

Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer

Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer

Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer

Validation of search filters for identifying pediatric studies in PubMed

Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study